Gender differences in achieving optimal lipid goals in patients with coronary artery disease

American Journal of Cardiology

Volumn 113, Issue 10, 2014, Pages 1611-1615

  Victor, Brett M ^a   Teal, Valerie ^b   Ahedor, Lilian ^c   Karalis, Dean G ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Lake Forest Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BILE ACID SEQUESTRANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DRUG POTENCY; ELECTRONIC MEDICAL RECORD; FEMALE; GOAL ATTAINMENT; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

AGED; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; OUTPATIENTS; PENNSYLVANIA; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SEX FACTORS; TREATMENT OUTCOME;

EID: 84899944811     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.02.018     Document Type: Article

References (17)

1. A.L. Blomkalns, A.Y. Chen, J.S. Hochman, E.D. Peterson, K. Trynosky, D.B. Diercks, G.X. Brogan, W.E. Boden, M.T. Roe, E.M. Ohman, B. Gibler, K. Newby CRUSADE Investigators Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Large-scale observations from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative J Am Coll Cardiol 45 2005 832 837
2. J. Dallongevillle, D. De Bacquer, J. Heidrich, G. De Backer, C. Prugger, K. Kotseva, M. Montaye, P. Amouyel EUROASPIRE Study Group Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event Heart 96 2010 1744 1749
3. N.K. Wenger, S.J. Lewis, F.K. Welty, D.M. Herrington, V. Bittner TNT Steering Committee and Investigators Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study Heart 94 2008 434 439
4. Q.A. Truong, S.A. Murphy, C.H. McCabe, A. Armani, C.P. Cannon TIMI Study Group Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22 Circ Cardiovasc Qual Outcomes 4 2011 328 336
5. W.J. Kostis, J.Q. Cheng, J.M. Dobrzynski, J. Cabrera, and J.B. Kostis Meta-analysis of statin effects in women versus men J Am Coll Cardiol 59 2012 572 582
6. J. Gutierrez, G. Ramirez, T. Rundek, and R.L. Sacco Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis Arch Intern Med 172 2012 909 919
7. L. Mosca, E.J. Benjamin, K. Berra, J.L. Bezanson, R.J. Dolor, D.M. Lloyd-Jones, L.K. Newby, I.L. Pina, V.L. Roger, L.J. Shaw, and D. Zhao Effectiveness-based guidelines for the prevention of cardiovascular disease in Women - 2011 update. A guideline from the American Heart Association Circulation 123 2011 1243 1262
8. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, and P.W.F. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation Nov 12, 2013 [Epub ahead of print]
9. L. Mosca, A.H. Linfante, E.J. Benjamin, K. Berra, S.N. Hayes, B.W. Walsh, R.P. Fabunmi, J. Kwan, T. Mills, and S.L. Simpson National study of physician awareness and adherence to cardiovascular disease prevention guidelines Circulation 111 2005 499 510
10. F. Turnbull, H. Arima, E. Heeley, A. Cass, J. Chalmers, C. Morgan, A. Patel, D. Peiris, A. Weekes, and C. Anderson Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study Eur J Cardiovasc Prev Rehabil 18 2011 498 503
11. D.C. Chan, W.H. Shrank, D. Cutler, S. Jan, M.A. Fischer, J. Liu, J. Avorn, D. Solomon, M.A. Brookhart, and N.K. Choudhry Patient, physician, and payment predictors of statin adherence Med Care 48 2010 196 202
12. A.H. Christian, T. Mills, S.L. Simpson, and L. Mosca Quality of cardiovascular disease preventive care and physician/practice characteristics J Gen Intern Med 21 2006 231 237
13. D.M. Mann, M. Woodard, P. Muntner, L. Falzon, and I. Kronish Predictors of non-adherence to statins: a systematic review and meta-analysis Ann Pharmacother 44 2010 1410 1421
14. R.C. Pasternak, S.C. Smith, C.N. Bairey-Merz, S.M. Grundy, J.I. Cleeman, and C. Lenfant ACC/AHA/NHLBI clinical advisory on the use and safety of statins J Am Coll Cardiol 40 2002 567 572
15. E. Bruckert, G. Hayem, S. Dejager, C. Yau, and B. Bégaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study Cardiovasc Drugs Ther 19 2005 403 414
16. G.A. Nichols, and C.E. Koro Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients Clin Ther 29 2007 1761 1770
17. C. Buettner, R.B. Davis, S.G. Leveille, M.A. Mittleman, and K.J. Mukamal Prevalence of musculoskeletal pain and statin use J Gen Intern Med 23 2008 1182 1186